Kolltan Pharmaceuticals Overview

Life ScienceCompany

Was Kolltan Pharmaceuticals formerly PE-backed?

Yes. Kolltan Pharmaceuticals was formerly owned by 1 private investor.

Where is Kolltan Pharmaceuticals headquartered?

Kolltan Pharmaceuticals is headquartered in New Haven, Connecticut.

What sector is Kolltan Pharmaceuticals in?

Kolltan Pharmaceuticals is a life science company.

When was Kolltan Pharmaceuticals founded?

Kolltan Pharmaceuticals was founded in 2007.

Kolltan Pharmaceuticals, Inc.

300 George Street, Suite 530,
New Haven, Connecticut 06511
United States,
(203) 773-3000
www.kolltan.com

Kolltan Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs).


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.